---
title: "TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287123284.md"
description: "TherapeuticsMD Inc. (TXMD) shares rose 1.96% to $2.08 on a strong trading day, marking the fourth consecutive day of gains. The NASDAQ Composite Index increased by 1.54%, while the Dow Jones Industrial Average rose 1.31%. TXMD remains 29.49% below its 52-week high of $2.95. In contrast, competitor AbbVie Inc. (ABBV) fell 0.68% to $212.30. Trading volume was below the 50-day average."
datetime: "2026-05-20T21:29:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287123284.md)
  - [en](https://longbridge.com/en/news/287123284.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287123284.md)
---

# TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) rallied 1.96% to $2.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.54% to 26,270.36 and the Dow Jones Industrial Average rising 1.31% to 50,009.35.

This was the stock's fourth consecutive day of gains.

TherapeuticsMD Inc. closed 29.49% short of its 52-week high of $2.95, which the company reached on January 27th.

The stock outperformed some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 0.68% to $212.30.

Trading volume (10,068) remained 11,924 below its 50-day average volume of 21,992.

Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-20-26 1729ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)